Want to Buy Pfizer (PFE) Stock? See This First.

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Pfizer, best known in popular culture for developing a widely-distributed COVID-19 vaccine, develops medications and vaccines in a wide range of disciplines. The firm should prove to remain in the news as COVID-19 variants Delta and Lambda become more widespread.

Step 1: Open up a brokerage account.

If you want to purchase PFE stock, you can try all the brokers on this list curated by Benzinga. Use these brokers to increase your net worth, learn more about your investments and centralize your finances.

Step 2: Select your number of shares. 

Choose the number of shares you wish to purchase using your budget and the stock’s current performance. Along with your budget, also consider:

• Fractional stocks if necessary
• Your position
• Industry news
• Current events

Step 3: Choose an order type.

The order type determines when the order will occur and at what price. Changing the order type alters the price you pay, how many shares you buy or sell, etc. Common orders include:

• Market orders, buying and selling at the current price
• Stop-loss orders, selling at a predetermined price before the stock drops too low
• Stop-limit orders, selling at a future price that proves to be higher and secures profits

Step 4: Execute your trade.

You can execute a trade with the click of a button on the broker’s site. However, you should check your account, ensure you know your account balance and review your holdings before making another investment.

PFE History

Use Benzinga Pro when you need information (like the chart below) on Pfizer or any other stock. The key to success and profitability is research. Benzinga gives you all the research tools you need, ensuring that you can buy into Pfizer or any other brand at exactly the right time, hold and sell successfully.

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.